| PBSV Stock | | | USD 0.50 0.05 9.09% |
CEO
Mr. Victor Sanchez is the President, Chief Executive Officer of the Company., effective January 1, 2015. Mr. Sanchez has served as the President of the European Operations of the Company since January 2011. Prior to joining the Company, he served as Operations Manager in the LOCM and OSD divisions of Merck Sharp Dohme, a pharmaceutical company, in Madrid, Spain from April 2010 to January 2011 and as Operations Manager of the LOCM division of ScheringPlough S.A., a pharmaceutical company, in Madrid, Spain, from September 2004 to April 2010. He served as Quality Control Validations Manager for ScheringPlough Products, LLC, a pharmaceutical company, in Puerto Rico from December 2000 to August 2004 and as Quality Control Laboratory Supervisor of ScheringPlough from April 1996 to December 2000. Mr. Sanchez holds a BS in Chemistry, summa cum laude, and a M.B.A. in Industrial Management, cum laude, from the Interamerican University of Puerto Rico. He holds a Post Graduate Diploma in Pharmaceutical Validation Technology from the Dublin Institute of Technology, Ireland. Mr. Sanchez is a licensed chemist by the Puerto Rico State Department and a member of the American Chemical Society, the Parenteral Drug Association, the Regulatory Affairs Professional Society, and the International Society for Pharmaceutical Engineers. since 2015.
| Age | 52 |
| Tenure | 9 years |
| Phone | 787 278 2709 |
| Web | https://www.pharmabioserv.com |
Pharma Bio Management Efficiency
The company has return on total asset
(ROA) of
0.033 % which means that it generated a profit of $0.033 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity
(ROE) of
0.0568 %, meaning that it created $0.0568 on every $100 dollars invested by stockholders. Pharma Bio's management efficiency ratios could be used to measure how well Pharma Bio manages its routine affairs as well as how well it operates its assets and liabilities.
Pharma Bio Serv currently holds 520.77
K in liabilities with Debt to Equity
(D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. Pharma Bio Serv has a current ratio of 8.89, suggesting that it is
liquid enough and is able to pay its financial obligations when due. Debt can assist Pharma Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Pharma Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pharma Bio Serv sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pharma to invest in growth at high rates of return. When we think about Pharma Bio's use of debt, we should always consider it together with cash and equity.
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico. Pharma Bio operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 190 people. Pharma Bio Serv [PBSV] is traded as part of a regulated electronic over-the-counter service offered by the NASD.
Management Performance
Pharma Bio Serv Leadership Team
Elected by the shareholders, the Pharma Bio's board of directors comprises two types of representatives: Pharma Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pharma. The board's role is to monitor Pharma Bio's management team and ensure that shareholders' interests are well served. Pharma Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pharma Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
Pharma Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Pharma Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Pharma OTC Stock Analysis
When running Pharma Bio's price analysis, check to
measure Pharma Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Bio is operating at the current time. Most of Pharma Bio's value examination focuses on studying past and present price action to
predict the probability of Pharma Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Bio's price. Additionally, you may evaluate how the addition of Pharma Bio to your portfolios can decrease your overall portfolio volatility.